3MH-22319-15460
4 vaccinations
4 coded responses
50 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 641 / MO
- Registered
- 2021-04-01
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-01
Registered in v-safe
-
2021-04-01
Dose 1 — Pfizer-BioNTech
-
2021-04-01
Health check-in — day 0, dose 1Feeling: Good · Site: Pain · Fatigue or tiredness, Abdominal painAdult check-in
-
2021-04-02
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-03
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-04-04
- 2021-04-05
- 2021-04-06
- 2021-04-07
- 2021-04-08
- 2021-04-15
- 2021-04-22
-
2021-04-23
Dose 2 — Pfizer-BioNTech
- 2021-04-23
-
2021-04-24
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-04-25
-
2021-04-26
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-04-27
-
2021-04-28
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Fatigue or tirednessAdult check-in
-
2021-04-29
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-04-30
- 2021-05-07
- 2021-05-14
- 2021-05-21
- 2021-05-28
- 2021-06-04
- 2021-07-23
- 2021-10-22
-
2021-11-05
Dose 3 — Pfizer-BioNTech
- 2021-11-05
-
2021-11-06
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Muscle or body aches, DiarrheaAdult check-in
-
2021-11-07
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Muscle or body aches, Fatigue or tiredness, DiarrheaAdult check-in
-
2021-11-08
Survey response — days 1–6 daily, dose 3MedDRA: Axillary pain, Oedema peripheral — Feeling: Fair · Site: Pain, SwellingFree text: Pain and swelling in underarm area on left side (left arm injection site)MedDRA releases: 2024-11 · check-in free text available
- 2021-11-09
- 2021-11-10
-
2021-11-11
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Fatigue or tiredness, Diarrhea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2021-11-12
-
2021-11-19
Survey response — day 14, dose 3MedDRA: Headache — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Morning headaches that tend to occur most mornings. Most resolve as the day goes on, but occasionally they may last all day or most of the day. There are more mornings with headaches than without.MedDRA releases: 2024-11 · check-in free text available
- 2021-11-26
- 2021-12-03
-
2021-12-10
Survey response — day 35, dose 3MedDRA: Hypersensitivity, Pre-existing disease — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Allergies have gotten significantly worseMedDRA releases: 2024-11 · check-in free text available
-
2021-12-17
Survey response — day 42, dose 3MedDRA: Cough, Dizziness, Eye pruritus, Fatigue, Hypersensitivity, Pre-existing disease, Respiratory tract congestion, Rhinorrhoea, Sneezing — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Worsening allergies/allergy symptoms, dizziness, lightheaded, fatigue, congestion, cough, runny nose, sneezing, itchy eyesMedDRA releases: 2024-11 · check-in free text available
- 2022-02-04
- 2022-05-06
-
2022-09-26
Dose 4 — Pfizer-BioNTechCo-administered: Flu
-
2022-09-29
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain, Swelling · Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2022-10-01
- 2022-10-03
- 2022-10-10
- 2022-10-17
- 2022-10-24
- 2022-10-31
- 2022-11-07
- 2022-12-26
- 2023-03-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-01 | Pfizer-BioNTech | |
| 2 | 2021-04-23 | Pfizer-BioNTech | |
| 3 | 2021-11-05 | Pfizer-BioNTech | No |
| 4 | 2022-09-26 | Pfizer-BioNTech | Flu |
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Pain and swelling in underarm area on left side (left arm injection site)
Release 10 — day 14, dose 3
Symptoms: Morning headaches that tend to occur most mornings. Most resolve as the day goes on, but occasionally they may last all day or most of the day. There are more mornings with headaches than without.
Release 10 — day 35, dose 3
Symptoms: Allergies have gotten significantly worse
Release 10 — day 42, dose 3
Symptoms: Worsening allergies/allergy symptoms, dizziness, lightheaded, fatigue, congestion, cough, runny nose, sneezing, itchy eyes
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Eye pruritus | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Hypersensitivity | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
| SRO | Axillary pain | · | · | ✓ |
| SRO | Oedema peripheral | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release